Skip to main content
In stock|Targeted Therapy

Bleximenib

Oncology TypeHematologic
Drug Class / MechanismEZH2 / Menin Inhibitor
No Image
Description

Bleximenib is classified as an EZH2 / Menin Inhibitor, sourced for use within our Targeted Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryTargeted Therapy
Oncology TypeHematologic

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3